Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01609985 · ClinicalTrials.gov registry record

Cutaneous Heart Sounds Data Collection During Cardiac Resynchronization Therapy (CRT) Optimization Study

A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
52
Enrollment target

NCT01609985 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 52 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01609985 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
52 participants
Enrollment target

Study Summary

The Cutaneous Heart Sounds Data Collection During CRT Optimization study is an acute, prospective, non-randomized multi-center feasibility clinical trial. The purpose of this clinical trial is to collect data to assist in the testing and finalization of a hemodynamic sensor-based cardiac resynchronization therapy (CRT) optimization scheme.

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2012-03
Est. Completion 2012-12

What the Registry Record Tells You About NCT01609985

The ClinicalTrials.gov registry entry for NCT01609985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01609985 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01609985 about?

NCT01609985 is a clinical study titled "Cutaneous Heart Sounds Data Collection During Cardiac Resynchronization Therapy (CRT) Optimization Study". The Cutaneous Heart Sounds Data Collection During CRT Optimization study is an acute, prospective, non-randomized multi-center feasibility clinical trial. The purpose of this clinical trial is to collect data to assist in the testing and finalization of a hemodynamic sensor-based cardiac resynchroni...

What is the current status of trial NCT01609985?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2012-03. Estimated completion is 2012-12.

Who is sponsoring clinical trial NCT01609985?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.